In silico Screening of Potential SARS-CoV-2 Main Protease Inhibitors from Thymus schimperi

In silico Screening of Potential SARS-CoV-2 Main Protease Inhibitors from Thymus schimperi

Hylemariam Mihiretie Mengist,1,&ast; Zunera Khalid,2,&ast; Fentahun Adane3 1Department of Medical Laboratory Science, College of Medical and Health Sciences, Debre Markos University, Debre Markos, Ethiopia; 2School of Basic Medical Sciences, Division of Life Sciences and Medicine, University...

Full description

Bibliographic Details
Main Authors:	Mengist HM, Khalid Z, Adane F
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-01-01
Series:	Advances and Applications in Bioinformatics and Chemistry
Subjects:	structural analysis sars-cov-2 main protease inhibitors thymus schimperi
Online Access:	https://www.dovepress.com/in-silico-screening-of-potential-sars-cov-2-main-protease-inhibitors-f-peer-reviewed-fulltext-article-AABC

Similar Items

In vivo Antidiabetic Activity Evaluation of Aqueous and 80% Methanolic Extracts of Leaves of Thymus schimperi (Lamiaceae) in Alloxan-induced Diabetic Mice
by: Melesie Taye G, et al.
Published: (2020-09-01)

Acute and developmental toxicity of embelin isolated from Embelia schimperi Vatke fruit: In vivo and in silico studies
by: Zelalem Animaw, et al.
Published: (2023-01-01)

CONTROL of Meloidogyne incognita and Pratylenchus zeae USING Embelia schimperi EXTRACTS
by: Beth Wangui Waweru, et al.
Published: (2022-03-01)

Potency, Safety, and Pharmacokinetic Profiles of Potential Inhibitors Targeting SARS-CoV-2 Main Protease
by: Hylemariam Mihiretie Mengist, et al.
Published: (2021-02-01)

2-Phenoxyacetamide derivatives as SARS-CoV-2 main protease inhibitor: In silico studies
by: Pandu Hariyono, et al.
Published: (2022-01-01)

Antioxidant and cardioprotective activity of Stachys schimperi Vatke against doxorubicin-induced cardiotoxicity
by: Essam Abdel-Sattar, et al.
Published: (2012-06-01)

Combined antibacterial effect of essential oils from three most commonly used Ethiopian traditional medicinal plants on multidrug resistant bacteria
by: Eshetu Gadisa, et al.
Published: (2019-01-01)

Evaluation of Anti-Inflammatory Activity of the Methanol Extracts of Premna schimperi Engl (Lamiaceae) Leaves in Rats
by: Arega M, et al.
Published: (2023-11-01)

Chemical constituents of the roots of Kniphofia schimperi and evaluation of their antimicrobial activity
by: Ebisa Mirete Deresa, et al.
Published: (2024-04-01)

Chemical, physical, and biological evaluation of hydro-distilled essential oil from leaves of Ethiopian thymus species
by: Yisgedu Asres, et al.
Published: (2024-12-01)

A Multistage In Silico Study of Natural Potential Inhibitors Targeting SARS-CoV-2 Main Protease
by: Eslam B. Elkaeed, et al.
Published: (2022-07-01)

In Silico Discovery of Small-Molecule Inhibitors Targeting SARS-CoV-2 Main Protease
by: Menghan Gao, et al.
Published: (2023-07-01)

Promising inhibitors against main protease of SARS CoV-2 from medicinal plants: In silico identification
by: EBENEZER OLUWAKEMI, et al.
Published: (2022-06-01)

Mechanistic Insights into the Inhibition of SARS-CoV-2 Main Protease by Clovamide and Its Derivatives: In Silico Studies
by: Naike Ye, et al.
Published: (2021-09-01)

Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach
by: Panthakarn Rangsinth, et al.
Published: (2021-03-01)

Investigation of antioxidant and antimicrobial activities of Euclea schimperi leaf extracts
by: Alemayehu Mekonnen, et al.
Published: (2018-08-01)

Wound Healing Effect of Acokanthera schimperi Schweinf (Apocynaceae) Methanol Leaf Extract Ointment in Mice and Its in-vitro Antioxidant Activity
by: Alemu BK, et al.
Published: (2020-12-01)

Identification of a Putative SARS-CoV-2 Main Protease Inhibitor through In Silico Screening of Self-Designed Molecular Library
by: Nanxin Liu, et al.
Published: (2023-07-01)

Molecular Docking of Novel 5-O-benzoylpinostrobin Derivatives as SARS-CoV-2 Main Protease Inhibitors
by: Mohammad Rizki Fadhil Pratama, et al.
Published: (2020-11-01)

Activity guided isolation of chemical constituents from the biologically active methanol extract of Euphorbia schimperi C. Presl
by: S. Ahmed, et al.
Published: (2018-01-01)

Inhibitory effect of thymoquinone from Nigella sativa against SARS-CoV-2 main protease. An in-silico study
by: M. T. Khan, et al.
Published: (2022-04-01)

Identification of possible SARS-CoV-2 main protease inhibitors: in silico molecular docking and dynamic simulation studies
by: Aniruddhya Mukherjee, et al.
Published: (2023-07-01)

Cathepsin inhibitors as potent inhibitors against SARS-CoV-2 main protease. In silico molecular screening and toxicity prediction
by: O. Sekiou, et al.
Published: (2023-02-01)

Search of Novel Small Molecule Inhibitors for the Main Protease of SARS-CoV-2
by: Wenfa Zhang, et al.
Published: (2023-02-01)

Synthesis of indole-based oxadiazoles and their interaction with bacterial peptidoglycan and SARS-CoV-2 main protease: In vitro, molecular docking and in silico ADME/Tox study
by: Mohammad Azam Ansari, et al.
Published: (2022-05-01)

Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease
by: Lukas van de Sand, et al.
Published: (2021-04-01)

Identification of Host Cellular Protein Substrates of SARS-COV-2 Main Protease
by: Márió Miczi, et al.
Published: (2020-12-01)

Triterpenic Acid Amides as Potential Inhibitors of the SARS-CoV-2 Main Protease
by: Dmitry S. Baev, et al.
Published: (2022-12-01)

In Silico Evaluation of Iranian Medicinal Plant Phytoconstituents as Inhibitors against Main Protease and the Receptor-Binding Domain of SARS-CoV-2
by: Seyyed Sasan Mousavi, et al.
Published: (2021-09-01)

Computational approach towards the design of artemisinin–thymoquinone hybrids against main protease of SARS-COV-2
by: Victor Moreira de Oliveira, et al.
Published: (2021-09-01)

Screening, Synthesis and Biochemical Characterization of SARS-CoV-2 Protease Inhibitors
by: Martynas Bagdonas, et al.
Published: (2023-08-01)

Statins and the COVID-19 main protease: in silico evidence on direct interaction
by: Željko Reiner, et al.
Published: (2020-04-01)

From Repurposing to Redesign: Optimization of Boceprevir to Highly Potent Inhibitors of the SARS-CoV-2 Main Protease
by: Matthias Göhl, et al.
Published: (2022-07-01)

In Silico Insights into the SARS CoV-2 Main Protease Suggest NADH Endogenous Defences in the Control of the Pandemic Coronavirus Infection
by: Annamaria Martorana, et al.
Published: (2020-07-01)

In silico study of medicinal plants with cyclodextrin inclusion complex as the potential inhibitors against SARS-CoV-2 main protease (Mpro) and spike (S) receptor
by: Doni Dermawan, et al.
Published: (2021-01-01)

Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel <i>In Silico</i> Method
by: Milan Sencanski, et al.
Published: (2020-08-01)

Support Vector Machine as a Supervised Learning for the Prioritization of Novel Potential SARS-CoV-2 Main Protease Inhibitors
by: Nedra Mekni, et al.
Published: (2021-07-01)

Systematic Search for SARS-CoV-2 Main Protease Inhibitors for Drug Repurposing: Ethacrynic Acid as a Potential Drug
by: Camilla Isgrò, et al.
Published: (2021-01-01)

Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188
by: Gordon J. Lockbaum, et al.
Published: (2021-01-01)

Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design
by: Wei Yu, et al.
Published: (2021-12-01)